LASA vs VIYASH: Stock Comparison

Lasa Supergenerics Limited vs Viyash Scientific Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Viyash Scientific Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lasa Supergenerics Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LASA is more favourable on 0 of 11 scored metrics and VIYASH on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,038 Cr vs ₹35 Cr
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹-6.8
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs -100%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
455% vs -139%
ROE
VIYASH has a higher ROE
11% vs -19.6%
ROCE
VIYASH has a higher ROCE
19% vs -18.2%
Net Margin
VIYASH has a higher net margin
6.57% vs -135.6%
Operating Margin
VIYASH has a higher operating margin
19.1% vs -29.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLASAVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricLASAVIYASH
Live Price₹6.86₹253.45
Day Change0.59%-2.41%
Volume9,6859.28 L
52-Week High₹14.08₹298
52-Week Low₹5.67₹178.13
Distance from 52W High-51.28%-14.95%

Valuation

MetricLASAVIYASH
Market Cap₹35 Cr₹11,038 Cr
P/E Ratio62.48x
P/B Ratio3.81x
EPS₹-6.8₹4.06
Book Value₹9.89₹66.6
Dividend Yield0%0%

Growth

MetricLASAVIYASH
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-100%129%
Qtr Profit Growth-139%455%

Profitability & Leverage

MetricLASAVIYASH
ROE-19.6%11%
ROCE-18.2%19%
Net Margin-135.6%6.57%
Operating Margin-29.3%19.1%
Debt to Equity0.2x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricLASAVIYASH
Promoter Holding53.65%0%
FII Holding0%4.5% 1.56 pp
DII Holding0%3.75% 4.24 pp
Public Holding46.35%30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lasa Supergenerics Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.